| Literature DB >> 32993037 |
Hao-Bing Yu1, Bin-Bin Gu2, Arihiro Iwasaki3, Wen-Li Jiang4, Andrew Ecker5, Shu-Ping Wang2, Fan Yang2, Hou-Wen Lin2.
Abstract
Chemical investigation on a marine sponge, Dactylospongia elegans, yielded five new γ-oxygenated butenolide sesterterpene derivatives, dactylospenes A-E (1-5), as well as two known biosynthetically related compounds, luffariellolide (6) and furospinosulin B (7). The structures of these compounds were elucidated on the basis of their spectroscopic data, experimental and calculated electronic circular dichroism (ECD) analysis, as well as comparison of the NMR data with those of known analogs. These metabolites are the first γ-oxygenated butenolide sesterterpenes to be reported from this genus. These compounds were evaluated in antimicrobial, anti-inflammatory, and cytotoxic assays. Only compounds 1, 3, and 6 exhibited moderate cytotoxicity against DU145, SW1990, Huh7, and PANC-1 cancer cell lines with IC50 values in the range of 2.11-13.35 μM. Furthermore, compound 2, without cytotoxicity, exhibited significant inhibitory effects (inhibitory rate 77.5%) on nitric oxide production induced by lipopolysaccharide at 10 μM.Entities:
Keywords: Dactylospongia; anti-inflammatory; cytotoxicity; hydroxybutenolide; sesterterpenes
Mesh:
Substances:
Year: 2020 PMID: 32993037 PMCID: PMC7600696 DOI: 10.3390/md18100491
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of compounds 1–7.
1H (400 MHz) and 13C NMR (100 MHz) spectroscopic data of 1.
| Position | δC | δH, Mult. ( | Position | δC | δH, Mult. ( |
|---|---|---|---|---|---|
|
| 171.6, C |
| 124.2, CH | 5.11, q (6.4) c | |
|
| 117.6, CH | 5.85, s |
| 135.0, C | |
|
| 169.5, C |
| 39.6, CH2 a | 2.00, m c | |
|
| 27.8, CH2 | 2.46, brd (30.8) |
| 26.5, CH2 b | 2.06, m c |
|
| 25.2, CH2 | 2.32, m |
| 123.9, CH | 5.11, q (6.4) c |
|
| 121.9, CH | 5.11, q (6.4) c |
| 131.3, C | |
|
| 137.4, C |
| 25.7, CH3 | 1.60, s c | |
|
| 39.7, CH2 a | 2.00, m c |
| 99.1, CH | 6.00, s |
|
| 26.8, CH2 b | 2.06, m c |
| 17.7, CH3 | 1.63, s c |
|
| 124.4, CH | 5.11, q (6.4) c |
| 16.0, CH3 | 1.60, s c |
|
| 135.3, C |
| 16.3, CH3 | 1.60, s c | |
|
| 39.7, CH2 a | 2.00, m c |
| 16.2, CH3 | 1.68, s c |
|
| 26.6, CH2 b | 2.06, m c |
a,b Values with identical superscript within each column may be interchanged; c Values with identical superscript within each column are mutually overlapped.
Figure 2COSY and key HMBC correlations for compounds 1–5.
Figure 3Selected NOESY correlations for compounds 1–5.
Figure 4Calculated electronic circular dichroism (ECD) spectra of the simplified models 8 (a) and 9 (b).
1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data of 2 and 3.
| Position | 2 | 3 | ||
|---|---|---|---|---|
| δC | δH, Mult. ( | δC | δH, Mult. ( | |
|
| 117.9, CH | 5.43, dd (4.2, 2.4) | 118.4, CH | 5.43, dd (4.2, 2.4) |
|
| 22.4, CH2 | 2.03, m | 22.9, CH2 | 2.03, m |
|
| 28.7, CH2 | 1.23, m | 28.5, CH2 | 1.23, m |
|
| 1.41, m | 1.41, m | ||
|
| 33.2, C | 33.9, C | ||
|
| 41.8, CH | 1.59, m | 42.5, CH | 1.59, m |
|
| 29.4, CH2 | 1.13, m | 29.9, CH2 | 1.13, m |
|
| 1.82, m | 1.82, m | ||
|
| 30.8, CH2 | 1.44, m | 31.3, CH2 | 1.44, m |
|
| 1.61, m | 1.61, m | ||
|
| 43.9, CH | 1.34, m | 44.4, CH | 1.34, m |
|
| 42.0, C | 43.1, C | ||
|
| 144.4, C | 145.0, C | ||
|
| 27.5, CH2 | 1.35, m | 28.2, CH2 | 1.35, m |
|
| 1.91, m | 1.91, m | ||
|
| 21.7, CH2 | 2.00, m | 22.3, CH2 | 2.00, m |
|
| 2.18, m | 2.18, m | ||
|
| 168.6, C | 169.1, C | ||
|
| 116.9, CH | 5.86, s | 117.5, CH | 5.86, s |
|
| 170.3, C | 170.8, C | ||
|
| 103.9, CH | 5.56, s | 104.4, CH | 5.61, s |
|
| 56.1, CH3 | 3.53, s | 56.5, CH3 | 3.50, s |
|
| 23.5, CH3 | 0.86, s | 23.9, CH3 | 0.84, s |
|
| 15.9, CH3 | 0.88, d (7.2) | 16.4, CH3 | 0.84, d (6.6) |
|
| 22.4, CH3 | 1.06, s | 23.0, CH3 | 1.04, s |
|
| 38.6, CH2 | 1.12, m | 39.1, CH2 | 1.02, m |
|
| 1.33, m | 1.39, m | ||
|
| 21.9, CH2 | 1.86, m | 22.4, CH2 | 1.90, m |
|
| 124.6, CH | 5.01, t (7.2) | 125.2, CH | 5.04, t (7.2) |
|
| 130.9, C | 130.9, C | ||
|
| 17.2, CH3 | 1.58, s | 17.6, CH3 | 1.59, s |
|
| 25.2, CH3 | 1.68, s | 25.7, CH3 | 1.66, s |
Figure 5Experimental CD spectrum (MeCN) of 2–5.
1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data of 4 and 5.
| Position | 4 | 5 | ||
|---|---|---|---|---|
| δC | δH, Mult. ( | δC | δH, Mult. ( | |
|
| 118.0, CH | 5.44, t (3.6) | 118.5, CH | 5.41, t (3.6) |
|
| 22.4, CH2 | 1.99, m | 23.0, CH2 | 1.98, m |
|
| 28.6, CH2 | 1.27, m | 28.6, CH2 | 1.27, m |
|
| 1.38, m | 1.38, m | ||
|
| 33.4, C | 34.0, C | ||
|
| 42.3, CH | 1.55, m | 43.4, CH | 1.53, m |
|
| 29.3, CH2 | 1.13, m | 29.9, CH2 | 1.11, m |
|
| 1.83, m | 1.81, m | ||
|
| 30.8, CH2 | 1.44, m | 31.3, CH2 | 1.42, m |
|
| 1.60, m | 1.59, m | ||
|
| 43.9, CH | 1.37, m | 44.4, CH | 1.36, m |
|
| 41.9, C | 42.5, C | ||
|
| 144.4, C | 145.1, C | ||
|
| 27.6, CH2 | 1.33, m | 28.1, CH2 | 1.32, m |
|
| 1.93, m | 1.91, m | ||
|
| 21.9, CH2 | 1.95, m | 22.5, CH2 | 2.01, m |
|
| 2.17, m | 2.11, m | ||
|
| 168.5, C | 169.0, C | ||
|
| 117.0, CH | 5.87, s | 117.5, CH | 5.85, s |
|
| 170.2, C | 170.8, C | ||
|
| 103.9, CH | 5.65, s | 104.5, CH | 5.61, s |
|
| 56.0, CH3 | 3.55, s | 56.8, CH3 | 3.54, s |
|
| 23.5, CH3 | 0.85, s | 24.0, CH3 | 0.83, s |
|
| 15.8, CH3 | 0.88, d (7.2) | 16.4, CH3 | 0.87, d (7.2) |
|
| 22.5, CH3 | 1.06, s | 23.0, CH3 | 1.04, s |
|
| 39.2, CH2 | 1.02, m | 39.8, CH2 | 0.95, m |
|
| 1.34, m | 1.33, m | ||
|
| 17.2, CH2 | 1.23, m | 17.8, CH2 | 1.23, m |
| 1.31, m | 1.29, m | |||
|
| 41.2, CH2 | 1.36, m | 41.1, CH2 | 1.35, m |
|
| 73.9, C | 74.6, C | ||
|
| 24.1, CH3 | 1.12, s | 24.9, CH3 | 1.11, s |
|
| 24.6, CH3 | 1.13, s | 25.0, CH3 | 1.12, s |
|
| 48.6, CH3 | 3.16, s | 49.1, CH3 | 3.16, s |
Cytotoxic activities of compounds 1–7 (IC50 in μM).
| Compound | DU145 | SW1990 | Huh7 | PANC-1 |
|---|---|---|---|---|
|
| 2.87 ± 0.63 | 2.11 ± 0.21 | 2.87 ± 0.23 | 7.59 ± 0.62 |
|
| >50 | >50 | >50 | >50 |
|
| 13.35 ± 1.41 | 7.40 ± 0.59 | 2.37 ± 0.23 | >50 |
|
| >50 | >50 | >50 | >50 |
|
| >50 | >50 | >50 | >50 |
|
| 3.21 ± 0.22 | 3.55 ± 0.31 | 3.61 ± 0.17 | 5.21 ± 0.55 |
|
| >50 | >50 | >50 | >50 |
| Cisplatin | 2.90 ± 0.39 | 5.09 ± 0.18 | 1.11 ± 0.11 | 4.59 ± 0.13 |